|
CHAC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.060800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.969400E-01 |
| Normal-vs-Stage2 |
9.129600E-01 |
| Normal-vs-Stage3 |
1.093840E-02 |
| Normal-vs-Stage4 |
8.496400E-03 |
| Stage1-vs-Stage2 |
5.956200E-01 |
| Stage1-vs-Stage3 |
5.978600E-03 |
| Stage1-vs-Stage4 |
7.261500E-03 |
| Stage2-vs-Stage3 |
4.470300E-02 |
| Stage2-vs-Stage4 |
2.448400E-02 |
| Stage3-vs-Stage4 |
5.181200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.707800E-01 |
| Normal-vs-AfricanAmerican |
7.240400E-03 |
| Normal-vs-Asian |
2.894000E-01 |
| Caucasian-vs-AfricanAmerican |
7.420800E-03 |
| Caucasian-vs-Asian |
7.699400E-01 |
| AfricanAmerican-vs-Asian |
7.245500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.444100E-02 |
| Normal-vs-Female |
3.300000E-01 |
| Male-vs-Female |
1.515240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.005200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.899750E-02 |
| Normal-vs-Age(61-80Yrs) |
3.791400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.619000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.082300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.450200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.964200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.380960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.015200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.059600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.200350E-02 |
| Classical-VS-Follicular |
5.393000E-01 |
| Classical-VS-Other |
5.762200E-01 |
| Classical-VS-Normal |
3.624800E-01 |
| Tall-VS-Follicular |
9.552100E-02 |
| Tall-VS-Other |
2.728200E-01 |
| Tall-VS-Normal |
1.183960E-02 |
| Follicular-VS-Other |
5.014000E-01 |
| Follicular-VS-Normal |
2.476800E-01 |
| Other-VS-Normal |
8.596400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.449200E-01 |
| Normal-vs-N1 |
4.461600E-02 |
| N0-vs-N1 |
1.568630E-01 |
|
|
